Aura Biosciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$112.8 | -$96.1 | -$85.0 | -$60.3 | -$35.2 |
| Net income | -$106.2 | -$86.9 | -$76.4 | -$58.8 | -$35.3 |
| Cash Flow Statement | |||||
| Free cash flow | -$85.2 | -$81.1 | -$64.6 | -$55.7 | -$34.5 |
Shares outstanding 103.4M · Free float 94.0%
Annual filing data through FY ended December 31, 2025; float as of August 31, 2026.